前收市價 | 7.97 |
開市 | 8.06 |
買盤 | 7.92 x 1300 |
賣出價 | 7.99 x 1100 |
今日波幅 | 7.81 - 8.11 |
52 週波幅 | 4.54 - 16.75 |
成交量 | |
平均成交量 | 6,695,680 |
市值 | 1.677B |
Beta 值 (5 年,每月) | -0.05 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.28 |
業績公佈日 | 2023年11月06日 - 2023年11月10日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 16.83 |
In the grand tapestry of the investment world, one thread that continues to shine is biotech stocks to buy and hold. It’s no secret that delving into biotech investments can be incredibly challenging, even when zeroing in on established firms with market-ready drugs and expansive research and development pipelines. In this arena, you’re not merely playing by the financial scorecards but placing bets on the future. These early-stage businesses dazzle with potential, yet their balance sheets typic
Biotech stocks may offer some of the most explosive opportunities on the market. For one, we have millions of baby boomers demanding better care. Two, there’s substantial demand for new innovative therapies, especially with gene editing. Three, multiple heavyweight companies are hunting for new drugs to keep their pipelines fresh with patent expirations nearing. Even better, according to The Wall Street Journal, biotech M&A is gaining big momentum. All because drug makers are facing a patent cli
In this piece, we will take a look at billionaire Stanley Druckenmiller’s small-cap stock picks. If you want to skip our introduction to Mr. Druckenmiller and small-cap stocks in general, then head on over to Billionaire Stan Druckenmiller’s Small-Cap Stock Picks: Top 5 Stocks. Stanley Druckenmiller is one of the richest people in the world. […]